CATAPLEXY
Clinical trials for CATAPLEXY explained in plain language.
Never miss a new study
Get alerted when new CATAPLEXY trials appear
Sign up with your email to follow new studies for CATAPLEXY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Once-Nightly pill may simplify narcolepsy treatment
Symptom relief CompletedThis study tested a new once-nightly medication (FT218) for people with narcolepsy who experience excessive daytime sleepiness and sudden muscle weakness (cataplexy). The goal was to see if it is safe and tolerable over the long term, and whether people currently taking a twice-n…
Matched conditions: CATAPLEXY
Phase: PHASE3 • Sponsor: Avadel • Aim: Symptom relief
Last updated May 26, 2026 05:06 UTC
-
New drug shows promise for narcolepsy symptom control
Symptom relief CompletedThis study tested the long-term safety and effectiveness of AXS-12 in 68 people with narcolepsy who experience sudden muscle weakness (cataplexy) and severe daytime sleepiness. Participants had already completed an earlier study of the same drug. The goal was to see if AXS-12 can…
Matched conditions: CATAPLEXY
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 05:05 UTC